Arch Capital Group Ltd. (ACGL)vsHelius Medical Technologies Inc Class A (HSDT)
ACGL
Arch Capital Group Ltd.
$88.34
+0.58%
FINANCIAL SERVICES · Cap: $32.03B
HSDT
Helius Medical Technologies Inc Class A
$1.48
-7.50%
FINANCIAL SERVICES · Cap: $74.15M
Smart Verdict
WallStSmart Research — data-driven comparison
Arch Capital Group Ltd. generates 206147% more annual revenue ($19.78B vs $9.59M). ACGL leads profitability with a 24.6% profit margin vs 0.0%. ACGL earns a higher WallStSmart Score of 79/100 (B+).
ACGL
Strong Buy79
out of 100
Grade: B+
HSDT
Hold37
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 94.6% YoY
Every $100 of equity generates 20 in profit
Keeps 25 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 7290.0% year-over-year
Areas to Watch
Revenue declined 3.3%
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -137.4% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ACGL
The strongest argument for ACGL centers on P/E Ratio, Price/Book, EPS Growth. Profitability is solid with margins at 24.6% and operating margin at 25.3%. PEG of 1.06 suggests the stock is reasonably priced for its growth.
Bull Case : HSDT
The strongest argument for HSDT centers on Price/Book, Revenue Growth. Revenue growth of 7290.0% demonstrates continued momentum.
Bear Case : ACGL
The primary concerns for ACGL are Revenue Growth, Altman Z-Score.
Bear Case : HSDT
The primary concerns for HSDT are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
ACGL profiles as a declining stock while HSDT is a hypergrowth play — different risk/reward profiles.
HSDT carries more volatility with a beta of 1.07 — expect wider price swings.
HSDT is growing revenue faster at 7290.0% — sustainability is the question.
ACGL generates stronger free cash flow (1.2B), providing more financial flexibility.
Bottom Line
ACGL scores higher overall (79/100 vs 37/100), backed by strong 24.6% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arch Capital Group Ltd.
FINANCIAL SERVICES · INSURANCE - DIVERSIFIED · USA
Arch Capital Group Ltd., offers insurance, reinsurance and mortgage products worldwide. The company is headquartered in Pembroke, Bermuda.
Helius Medical Technologies Inc Class A
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Compare with Other INSURANCE - DIVERSIFIED Stocks
Want to dig deeper into these stocks?